A detailed history of California State Teachers Retirement System transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, California State Teachers Retirement System holds 177,253 shares of BCRX stock, worth $1.35 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
177,253
Previous 182,868 3.07%
Holding current value
$1.35 Million
Previous $1.13 Million 19.2%
% of portfolio
0.0%
Previous 0.0%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$6.41 - $8.69 $35,992 - $48,794
-5,615 Reduced 3.07%
177,253 $1.35 Million
Q2 2024

Aug 14, 2024

SELL
$4.13 - $6.79 $7,929 - $13,036
-1,920 Reduced 1.04%
182,868 $1.13 Million
Q1 2024

May 15, 2024

SELL
$4.89 - $7.65 $74,195 - $116,073
-15,173 Reduced 7.59%
184,788 $938,000
Q4 2023

Feb 13, 2024

SELL
$4.98 - $6.77 $43,898 - $59,677
-8,815 Reduced 4.22%
199,961 $1.2 Million
Q3 2023

Nov 14, 2023

SELL
$6.71 - $7.92 $134,884 - $159,207
-20,102 Reduced 8.78%
208,776 $1.48 Million
Q2 2023

Aug 21, 2023

SELL
$6.96 - $8.81 $27,178 - $34,403
-3,905 Reduced 1.68%
228,878 $1.61 Million
Q1 2023

May 09, 2023

SELL
$7.94 - $11.84 $24,351 - $36,313
-3,067 Reduced 1.3%
232,783 $1.94 Million
Q4 2022

Feb 14, 2023

BUY
$10.5 - $14.2 $30,250 - $40,910
2,881 Added 1.24%
235,850 $2.71 Million
Q3 2022

Nov 18, 2022

SELL
$10.79 - $14.81 $42,253 - $57,995
-3,916 Reduced 1.65%
232,969 $2.94 Million
Q2 2022

Aug 15, 2022

BUY
$7.89 - $17.88 $47,947 - $108,656
6,077 Added 2.63%
236,885 $2.51 Million
Q1 2022

May 16, 2022

SELL
$11.56 - $19.76 $211,351 - $361,272
-18,283 Reduced 7.34%
230,808 $3.75 Million
Q4 2021

Feb 15, 2022

BUY
$11.18 - $15.46 $77,958 - $107,802
6,973 Added 2.88%
249,091 $3.45 Million
Q3 2021

Nov 15, 2021

SELL
$14.21 - $17.65 $41,720 - $51,820
-2,936 Reduced 1.2%
242,118 $3.48 Million
Q2 2021

Aug 16, 2021

SELL
$9.5 - $17.24 $202,397 - $367,298
-21,305 Reduced 8.0%
245,054 $3.87 Million
Q1 2021

May 18, 2021

SELL
$7.37 - $13.61 $7,259 - $13,405
-985 Reduced 0.37%
266,359 $2.71 Million
Q3 2020

Nov 17, 2020

BUY
$3.43 - $5.53 $114,249 - $184,198
33,309 Added 14.23%
267,344 $918,000
Q2 2020

Aug 17, 2020

BUY
$1.9 - $5.61 $9,843 - $29,065
5,181 Added 2.26%
234,035 $1.12 Million
Q1 2020

May 13, 2020

BUY
$1.6 - $4.11 $4,219 - $10,838
2,637 Added 1.17%
228,854 $458,000
Q4 2019

Feb 14, 2020

BUY
$1.59 - $3.45 $86,855 - $188,459
54,626 Added 31.84%
226,217 $780,000
Q3 2019

Nov 15, 2019

BUY
$2.5 - $3.73 $8,255 - $12,316
3,302 Added 1.96%
171,591 $492,000
Q1 2019

May 09, 2019

SELL
$7.38 - $9.72 $74,914 - $98,667
-10,151 Reduced 5.69%
168,289 $1.37 Million
Q4 2018

Feb 13, 2019

BUY
$6.51 - $9.6 $74,917 - $110,476
11,508 Added 6.89%
178,440 $1.44 Million
Q3 2018

Nov 14, 2018

BUY
$5.52 - $7.99 $89,556 - $129,629
16,224 Added 10.77%
166,932 $1.27 Million
Q2 2018

Aug 14, 2018

BUY
$4.6 - $6.52 $6,830 - $9,682
1,485 Added 1.0%
150,708 $864,000
Q1 2018

May 15, 2018

SELL
$4.35 - $5.82 $22,759 - $30,450
-5,232 Reduced 3.39%
149,223 $712,000
Q4 2017

Feb 14, 2018

BUY
$4.16 - $5.33 $109,865 - $140,765
26,410 Added 20.63%
154,455 $758,000
Q3 2017

Nov 13, 2017

BUY
$4.1 - $5.97 $524,984 - $764,428
128,045
128,045 $671,000

Others Institutions Holding BCRX

About BIOCRYST PHARMACEUTICALS INC


  • Ticker BCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,944,992
  • Market Cap $1.41B
  • Description
  • BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...
More about BCRX
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.